Publicou 4 edições por ano
ISSN Imprimir: 0893-9675
ISSN On-line: 2162-6448
Indexed in
Aging and Cancer Vaccines
RESUMO
Cancer vaccination is less effective at old than at young age, due to T cell unresponsiveness. This is caused by age-related changes of the immune system. Major immune defects at older age are lack of naive T cells, impaired activation pathways of T cells and antigen-presenting cells (APC), and age-related changes in the tumor microenvironment (TME). Also innate immune responses are affected by aging, but this seems less abundant than adaptive immune responses. In this review we compared various cancer vaccine studies at young and old age, demonstrating the importance of both innate and adaptive immune responses for cancer immunotherapy. Moreover, we found suggestive evidence that innate immune responses could help improve adaptive immune responses through cancer vaccination in old age.
-
Abusarah Jamilah, Khodayarian Fatemeh, Cui Yun, El-Kadiry Abed El-Hakim, Rafei Moutih, Thymic Rejuvenation: Are We There Yet?, in Gerontology, 2018. Crossref
-
Chertkova A. I., Zabotina T. N., Tsiklauri V. T., Zakharova E. N., Tabakov D. V., Borunova A. A., Shoua E. K., Zaderenko I. A., Vorotnikov I. K., Mudunov A. M., Kadagidze Z. G., AGE-RELATED FEATURES OF SYSTEMIC ANTITUMOR IMMUNE RESPONSE IN PATIENTS WITH PRIMARY OPERABLE BREAST CANCER AND CANCER OF THE ORAL MUCOSA, Russian Journal of Biotherapy, 19, 1, 2020. Crossref
-
Tye Gee Jun, Ioannou Kyriaki, Amofah Eunice, Quartey-Papafio Ruby, Westrop Samantha J., Krishnamurthy Pramila, Noble Alistair, Harrison Phillip M., Gaensler Karin M.L., Barber Linda D., Farzaneh Farzin, The combined molecular adjuvant CASAC enhances the CD8+ T cell response to a tumor-associated self-antigen in aged, immunosenescent mice, Immunity & Ageing, 12, 1, 2015. Crossref
-
Kaeberlein Matt, Rabinovitch Peter S., Martin George M., Healthy aging: The ultimate preventative medicine, Science, 350, 6265, 2015. Crossref